LOUISVILLE, Ky.–(BUSINESS WIRE)–Turning Point Brands, Inc. (NYSE: TPB) announced the date and time for its conference call to review third quarter 2026 results. The conference call will be on Monday, November 9th at 9:00 a.m. Eastern Time. Webcast Link: https://events.q4inc.com/attendee/633308822 Analyst Dial-ins: North America (Toll-Free): +1 833 461 5787 International (Toll): +1 585 542 9983 International Dial-Ins Meeting ID: 633 308 822 Analyst Pre-Registration Link The registration link e
Author: sHq_LoGiNz
BOSTON–(BUSINESS WIRE)–Silversmith Capital Partners, a growth equity firm focused on supporting the best entrepreneurs in technology and healthcare, today announced the appointment of Jean Gulliver as Head of Investor Relations. In this role, Jean will lead the firm’s institutional investor relationships and capital formation efforts. “Jean is someone I’ve known and respected for years, and we couldn’t be more excited to welcome her to Silversmith,” said Lori Whelan, Managing Partner & CO
SMITHS FALLS, Ontario–(BUSINESS WIRE)–Canopy Growth Corporation (“Canopy Growth”, “our”, “we” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a leading global company committed to bettering lives through cannabis, today announced the voting results from its annual general and special meeting of shareholders convened on September 25, 2026, and adjourned to and reconvened on October 23, 2026 (the “Meeting”). A total of 154,837,897 common shares of the Company (the “Shares”), representing 36.60% of
GENEVA–(BUSINESS WIRE)–Light Chain Bioscience, a clinical-stage biotechnology company advancing the next generation of bispecific antibodies to treat cancer, today presented updated long-term results from a Phase 1/1b study of NI-1801 as a monotherapy and in combination with pembrolizumab in heavily pretreated Platinum Resistant Ovarian Cancer (PROC) patients that have no approved standard of care treatment. The data were reported in a Poster presentation at European Society of Medical Oncolo
GENÈVE–(BUSINESS WIRE)–Light Chain Bioscience, société de biotechnologie Suisse en phase clinique qui développe la prochaine génération d’anticorps bispécifiques pour le traitement du cancer, a présenté aujourd’hui des résultats actualisés à long terme d’une étude de phase 1/1b évaluant NI-1801 en monothérapie et en association avec le pembrolizumab chez des patientes lourdement prétraitées atteintes d’un cancer de l’ovaire résistant au platine (PROC), pour lesquelles il n’existe aucun traite
GENF–(BUSINESS WIRE)–Light Chain Bioscience, ein Schweizer klinisches Biotechnologieunternehmen, das die nächste Generation bispezifischer Antikörper zur Krebsbehandlung vorantreibt, hat heute aktualisierte Langzeitergebnisse einer Phase-1/1b-Studie zu NI-1801 als Monotherapie und in Kombination mit Pembrolizumab bei stark vorbehandelten Patientinnen mit platinresistentem Ovarialkarzinom (PROC) vorgestellt, für die keine zugelassene Standardtherapie existiert. Die Daten wurden in einer Poster
LOS ANGELES–(BUSINESS WIRE)—- $FTK–FTK Investors Have Opportunity to Lead Flotek Industries, Inc. Securities Fraud Lawsuit with SBS Law
MIDLAND, Texas–(BUSINESS WIRE)—- $ASTS #AST–AST SpaceMobile, Inc. (“AST SpaceMobile”) (NASDAQ: ASTS), the company building the first and only space-based cellular broadband network accessible directly by everyday smartphones, designed for both commercial and government applications, today announced significant progress toward bringing space-based cellular broadband to Brazil, Latin America’s largest economy. AST SpaceMobile has secured S-band spectrum authorization from Brazil’s National Telecommunication
CHARLESTON, W.Va.–(BUSINESS WIRE)–City Holding Company Announces Record Quarterly Results
LAS VEGAS–(BUSINESS WIRE)–Realbotix Corp. (TSX-V: XBOT) (Frankfurt: 76M0.F) (OTC: XBOTF) (“Realbotix” or the “Company”), a manufacturer of humanoid robots and AI systems, announces the launch of its new flagship robot platform, Echo. Designed for companionship, education, and wellness, Echo robots are built to support meaningful human-to-robot interaction. Its streamlined modular architecture makes it easy for customers to configure robots that deliver practical value in social and personal e